Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Dec 29, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc.
|
0
|
$145.73 | -$2,956,500.00 |
—
| 16.03K |
Dec 27
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 16.03K |
$185.38 | -$1,195,310.07 |
∞
| 16.03K |
Aug 2 - Aug 3
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 2
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 15
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Kaleido Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 30 - Jun 30
| |||||||
Bristol Myers Squibb Co
| 902 |
—
|
—
| +7.78% | 12.5K |
Jun 13
| |||||||
Bristol Myers Squibb Co
| 2.95K |
—
|
—
| +34.09% | 11.6K |
Jun 3
| |||||||
Magenta Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Mar 31
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Dec 31
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Sep 30
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Kaleido Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Bristol Myers Squibb Co
| 1.46K |
—
|
—
| +20.32% | 8.65K |
Jun 13 - Jun 14
| |||||||
Bristol Myers Squibb Co
| 88 |
$58.90 | $5,183.20 | +1.24% | 7.19K |
Dec 4
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
| ||||||||
Magenta Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 5
| |||||||
Bristol Myers Squibb Co
| 2.95K |
—
|
—
| +69.55% | 7.19K |
Jun 3
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Mar 31
| |||||||
Sarepta Therapeutics, Inc.
| 2.08K |
—
|
—
| +29.43% | 9.13K |
Feb 28
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Dec 31
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
| ||||||||
Bristol Myers Squibb Co
| 6.07K |
—
|
—
|
∞
| 6.07K |
Nov 20
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Nov 20
| |||||||
Celgene Corp /de/
| -4.21K |
—
|
—
| -100.00% |
0
|
Nov 20
| |||||||
Sarepta Therapeutics, Inc.
| 2K |
$86.74 | $173,480.00 | +39.60% | 7.05K |
Sep 9
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Celgene Corp /de/
| 1.16K |
—
|
—
| +110.38% | 2.21K |
Jun 13 - Jun 15
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 11
| |||||||
Magenta Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Celgene Corp /de/
|
0
|
—
|
—
|
—
|
0
|
Jun 3
| |||||||
Kaleido Biosciences, Inc.
| 714.19K |
$13.98 |
—
| +76.22% | 1.65M |
Feb 28 - Mar 4
| |||||||
Sarepta Therapeutics, Inc.
| 1.63K |
—
|
—
| +47.78% | 5.05K |
Mar 4
| |||||||
Kaleido Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Magenta Therapeutics, Inc.
| 21.85K |
—
|
—
| +11.29% | 215.35K |
Jun 25
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.